Stocks closed sharply down on Monday, with the Dow dropping almost 200 points, after a Federal Reserve official said the central bank will continue to taper off its stimulus and several companies warned of poor quarterly results.
The Dow Jones Industrial Average posted its worst session since Sept. 20 and closed 179 points, or 1.1 percent, down, with 29 of its 30 components finishing in the red. The S&P 500 lost 23 points, or 1.26 percent, and the Nasdaq was 61 points lower -- a 1.47 percent drop -- on a day when earnings reports began in earnest .
Stocks slumped after a speech Monday afternoon by Atlanta Federal Reserve President Dennis Lockhart, in which he said that if all goes as expected, the central bank would continue to ease off its monthly bond purchases.
"One driver is we're off to a mixed start to the earnings season; negative pre-announcements exceed positive by a record 10-to-1 margin, so the bar has been set very low," said Alan Skrainka, chief investment officer at Cornerstone Wealth Management.
Equities had been "drifting lower, then Fed comments provided an extra leg down," said Dan Greenhaus, chief market strategist at BTIG. But, "stocks have been trading poorly for a couple of days now in front of earnings," with some people looking to corporate results to justify last year's performance, which had the S&P 500 rising more than 29 percent," Greenhaus added.
Calling S&P 500 valuation lofty by nearly any measure, Goldman said stocks could be primed for a pullback.
Apart from some major event, a rise in interest rates "in an accelerated manner" rather than a controlled one could spark a market correction of 10 percent, said Tim Speiss, a vice president at EisnerAmper Wealth Planning, who added that he was not forecasting such an event.
Merck & Co. was the sole blue-chip gainer, up 6.5 percent. A preliminary review posted on the U.S. Food and Drug Administration's web site had the agency citing "robustly positive" clinical trial results in saying its blood clot-preventing drug vorapaxar should be approved.
Beam surged 24 percent after Japan's Suntory Holdings said it would acquire the maker of Jim Beam and Maker's Mark bourbons in a deal with a total value of $16 billion. Lululemon Athletica slid after the sportswear retailer cut its profit and sales outlook for the fourth quarter.
Symantec fell after Morgan Stanley advised investors sell shares of the anti-virus software manufacturer. Juniper Networks surged after Bloomberg cited two people familiar with the matter in reporting the maker of computer-networking equipment was being targeted by activist hedge fund Elliott Management.
About two dozen S&P 500 companies will report in the coming week, with JPMorgan Chase and Wells Fargo kicking off the season Tuesday morning. Intel reports Thursday, and General Electric on Friday.
For every share that rose, more than two fell on the New York Stock Exchange, where nearly 733 million shares traded. Composite volume neared 3.6 billion.
"The selloff accelerated to the downside after comments from the Fed's Lockhart. It sounded boiler plate to me," noted Elliot Spar, market strategist at Stifel, Nicolaus & Co.
"The Fed wants out of QE (quantitative easing) and the one data point of Friday's payroll disappointment is not going to be enough to change that," said Peter Boockvar, chief market analyst at the Lindsey Group, referring to the December jobs report, which came in significantly below expectations.
The dollar edged lower against the currencies of major U.S. trading partners and the yield on the 10-year Treasury note dropped 14 basis points to 2.828 percent.
The price of crude-oil futures for February delivery fell 92 cents to $91.80 a barrel; gold futures for February delivery rose $4.20 to $1,251.10 an ounce.
"Early indications suggest a strong year-over-year gain (from a weak base) to close to $28 in S&P 500 earnings," wrote David Kelly, chief global strategist at J.P. Morgan Funds, in an emailed research note.